Dilution of Share Value Through Exercise of Stock Acquisition Rights
First written in FY2017. 6 of 23 entries say "Restated". Latest entry: FY2026-H1.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026-H1Diluted EPS calculation updatedAnnual report
「Diluted interim net income per share ¥9.12 (Basis of calculation) Interim net income adjustments (¥ thousands) — Increase in common shares (shares) 65,308」
Diluted interim net income per share was ¥9.12, and the increase in common shares used in the calculation was 65,308 shares. No significant changes in potential shares from the end of the previous fiscal year were reported. - FY2025MitigatedAnnual report
「As of the end of the month preceding the month in which this document was filed, the number of potential shares was 2,348,500, equivalent to 10.4% of the total of 22,680,000 issued shares.」
The number of potential shares decreased from 2,357,500 in the previous fiscal year to 2,348,500. The ratio to total issued shares remained unchanged at 10.4%. - FY2024WorsenedAnnual report
「As of the end of the month preceding the date of filing this document, the number of potential shares was 2,357,500, equivalent to 10.4% of the total number of shares issued, 22,680,000.」
The number of potential shares increased from 2,032,720 shares, or 9.0%, in the previous fiscal year to 2,357,500 shares, or 10.4%, increasing dilution exposure. - FY2024-Q1RestatedAnnual report
「① [Details of the stock option plan] Not applicable. ② [Status of other stock acquisition rights, etc.] Not applicable.」
No new stock option plan or other stock acquisition rights were disclosed for the quarter. - FY2023WorsenedAnnual report
「As of the end of the month preceding the date of filing this document, the number of potential shares was 2,032,720, equivalent to 9.0% of the total number of shares issued, 22,680,000.」
The number of potential shares increased from 1,505,120, or 6.6%, in the previous fiscal year to 2,032,720, or 9.0%, expanding dilution exposure. - FY2023-Q3Diluted EPS calculation updatedAnnual report
「(2) Diluted quarterly net income per share ¥19.28 (Basis of calculation) Adjustment to quarterly net income (¥ thousand) None Increase in common shares (shares) 3,730」
Diluted quarterly net income per share was disclosed as ¥19.28, based on an increase of 3,730 common shares. No potential shares with a material change since the end of the previous fiscal year were identified. - FY2023-Q2RestatedAnnual report
「Number of stock acquisition rights (rights)* 1,853,600 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 1,853,600 (Note 2)」
The 1,853,600 Series 12 stock acquisition rights, the 1,853,600 underlying common shares and the exercise period have been reiterated. The potential share capacity is unchanged from the disclosure in the previous quarter. - FY2023-Q1Restructuring of dilution capacity through new issuance and cancellation of existing stock acquisition rightsAnnual report
「Total number of stock acquisition rights 1,853,600 (1 share per stock acquisition right) Class and number of shares underlying the stock acquisition rights Common shares of the company: 1,853,600 shares Number of stock acquisition rights to be cancelled (number of shares) 1,024,000 rights (1,024,000 shares) Number of stock acquisition rights remaining after cancellation (number of shares) 140,000 rights (140,000 shares)」
While 1,853,600 Series 12 stock acquisition rights equivalent to 1,853,600 shares will be newly issued, 1,024,000 existing Series 11 stock acquisition rights will be cancelled, leaving 140,000 rights outstanding. The composition of potential shares has changed. - FY2022MitigatedAnnual report
「As of the end of the month preceding the date of filing this document, the number of potential shares was 1,505,120, equivalent to 6.6% of the total number of shares issued, 22,680,000.」
The number of potential shares decreased from 1,942,200 in the previous fiscal year to 1,505,120, while the proportion of total shares issued decreased from 8.6% to 6.6%. Dilution exposure has therefore narrowed numerically. - FY2022-Q2Update to diluted earnings calculation figuresAnnual report
「(2) Diluted quarterly net income per share ¥12.15 (Basis of calculation) Adjustment to quarterly net income (¥ thousand) None Increase in common shares (shares) 31,484」
Diluted quarterly net income per share was disclosed as ¥12.15, based on an increase of 31,484 common shares. No potential shares with a material change since the end of the previous fiscal year were identified. - FY2022-Q1RestatedAnnual report
「Diluted quarterly net income per share ¥3.41 Overview of potential shares that were excluded from the calculation of diluted quarterly net income per share because they had no dilutive effect and had undergone a material change since the end of the previous fiscal year None」
Diluted quarterly net income per share was disclosed, and no potential shares with a material change since the end of the previous fiscal year were identified. - FY2021MitigatedAnnual report
「As of the end of the month preceding the date of filing this document, the number of potential shares was 1,942,200, equivalent to 8.6% of the total number of shares issued, 22,680,000.」
The number of potential shares decreased from 2,110,598 in the previous fiscal year to 1,942,200, while the proportion of total shares issued decreased from 9.3% to 8.6%. - FY2021-Q3Update to diluted earningsAnnual report
「(2) Diluted quarterly net income per share ¥43.47 (Basis of calculation) Adjustment to quarterly net income (¥ thousand) None Increase in common shares (shares) 18,797 Overview of potential shares that were excluded from the calculation of diluted quarterly net income per share because they had no dilutive effect and had undergone a material change since the end of the previous fiscal year None」
Diluted quarterly net income per share was disclosed as ¥43.47, based on an increase of 18,797 common shares. No potential shares with a material change since the end of the previous fiscal year were identified. - FY2021-Q2Update to diluted earningsAnnual report
「(2) Diluted quarterly net income per share ¥29.20 (Basis of calculation) Adjustment to quarterly net income (¥ thousand) None Increase in common shares (shares) 27,074 Overview of potential shares that were excluded from the calculation of diluted quarterly net income per share because they had no dilutive effect and had undergone a material change since the end of the previous fiscal year None」
Diluted quarterly net income per share was disclosed as ¥29.20, based on an increase of 27,074 common shares. No potential shares with a material change since the end of the previous fiscal year were identified. - FY2020MitigatedAnnual report
「As of the end of the month preceding the date of filing this document, the number of potential shares was 2,110,598, equivalent to 9.3% of the total number of shares issued, 22,680,000.」
The number of potential shares decreased from 2,221,718 in the previous fiscal year to 2,110,598, while the proportion of total shares issued decreased from 9.8% to 9.3%. - FY2020-Q3Update to diluted earningsAnnual report
「(2) Diluted quarterly net income per share ¥7.65 (Basis of calculation) Increase in common shares (shares) 55,507 Overview of potential shares that were excluded from the calculation of diluted quarterly net income per share because they had no dilutive effect and had undergone a material change since the end of the previous consolidated fiscal year None」
Diluted quarterly net income per share was disclosed as ¥7.65, based on an increase of 55,507 common shares. No potential shares with a material change since the end of the previous consolidated fiscal year were identified. - FY2020-Q1RestatedAnnual report
「Diluted quarterly net income per share: ¥8.50 Increase in common shares (shares): 92,951 Overview of potential shares that were excluded from the calculation of diluted quarterly net income per share because they had no dilutive effect and had undergone a material change since the end of the previous consolidated fiscal year: None」
Diluted quarterly net income per share was calculated using an increase of 92,951 common shares. No potential shares with a material change since the end of the previous consolidated fiscal year were identified. - FY2019MitigatedAnnual report
「As of the end of the month preceding the date of filing this document, the number of potential shares was 2,221,718, equivalent to 9.8% of the total number of shares issued, 22,680,000.」
The number of potential shares was 2,221,718, or 9.8% of total shares issued, down from 2,462,260 shares and 10.9% in the previous annual report. - FY2019-Q3RestatedAnnual report
「Diluted quarterly net income per share: ¥45.37 Increase in common shares (shares): 470,634 Overview of potential shares that were excluded from the calculation of diluted quarterly net income per share because they had no dilutive effect and had undergone a material change since the end of the previous fiscal year: None」
Diluted quarterly net income per share was calculated using an increase of 470,634 common shares. No potential shares with a material change since the end of the previous fiscal year were identified as having been excluded from the calculation due to their lack of dilutive effect, and no new material dilution factors were disclosed. - FY2018WorsenedAnnual report
「As of the end of the month preceding the date of filing this document, the number of potential shares was 2,462,260, equivalent to 10.9% of the total number of shares issued, 22,680,000.」
The number of potential shares was disclosed as 2,462,260, or 10.9% of total shares issued, with the proportion of dilution exposure increasing from 10.3% in the previous annual report. - FY2018-Q2RestatedAnnual report
「The Series 10 stock acquisition rights issued during the second quarter accounting period are as follows. Number of stock acquisition rights (rights) 238,750 Number of shares underlying the stock acquisition rights (shares) 238,750 (Note 2) Exercise period for the stock acquisition rights From 31 March 2019 To 30 March 2028」
The 238,750 Series 10 stock acquisition rights, the 238,750 underlying shares and the exercise period have been reiterated. This filing contains no disclosure of new issuance or exercise, and potential share exposure from future exercise remains. - FY2018-Q1WorsenedAnnual report
「Total number of stock acquisition rights: 238,750 (1 share per stock acquisition right)」
The decision to issue 238,750 stock acquisition rights to directors and employees was disclosed as a material subsequent event, adding potential share and dilution exposure upon future exercise. The rights have not yet been exercised. - FY2017First statedAnnual report
「As of the end of the month preceding the date of filing this document, the number of potential shares from stock options was 1,172,480, equivalent to 10.3% of the total number of shares issued, 11,340,000.」
The 1,172,480 potential shares from stock options were equivalent to 10.3% of total shares issued, quantifying the potential dilution of equity value upon exercise.